Discouraging Federal actions that reduce the value of private property: evaluating procedural and financial approaches

A regulatory taking occurs when a court concludes that a government action has taken private property for a public use without paying just compensation to the owner--a violation of the fifth amendment. Often, the remedy is a monetary award whose value is determined by the court. ; In recent years there has been considerable interest in creating a statutory complement to the constitutional law of takings. Some believe that a statutory scheme, using procedural financial approaches, would discourage federal regulatory activities that reduce the value of privately owned property. The procedural approach would require federal agencies to evaluate the property value effects of proposed actions before undertaking them. The financial approach would require that federal agencies pay from their own budgets for any compensation awards that result from their decisions. ; This paper compares the existing procedural and financial approaches to the ones proposed. It describes the model of agency incentives and the regulatory environment implicitly assumed by these proposals and compares them to the literature on regulatory decision making and administrative law. Finally, the paper discusses some of the institutional factors likely to affect the outcome of the proposed reforms, including the role of the courts in enforcing analysis requirements, the extent of agency discretion, and the federal budget process.Environmental protection

Late metal-silicate separation on the IAB parent asteroid: Constraints from combined W and Pt isotopes and thermal modelling

The short-lived $^{182}$Hf-$^{182}$W decay system is a powerful chronometer for constraining the timing of metal-silicate separation and core formation in planetesimals and planets. Neutron capture effects on W isotopes, however, significantly hamper the application of this tool. In order to correct for neutron capture effects, Pt isotopes have emerged as a reliable in-situ neutron dosimeter. This study applies this method to IAB iron meteorites, in order to constrain the timing of metal segregation on the IAB parent body. The $\epsilon^{182}$W values obtained for the IAB iron meteorites range from -3.61 $\pm$ 0.10 to -2.73 $\pm$ 0.09. Correlating $\epsilon^{\mathrm{i}}$Pt with $^{182}$W data yields a pre-neutron capture $^{182}$W of -2.90 $\pm$ 0.06. This corresponds to a metal-silicate separation age of 6.0 $\pm$ 0.8 Ma after CAI for the IAB parent body, and is interpreted to represent a body-wide melting event. Later, between 10 and 14 Ma after CAI, an impact led to a catastrophic break-up and subsequent reassembly of the parent body. Thermal models of the interior evolution that are consistent with these estimates suggest that the IAB parent body underwent metal-silicate separation as a result of internal heating by short-lived radionuclides and accreted at around 1.4 $\pm$ 0.1 Ma after CAIs with a radius of greater than 60 km.Comment: 11 pages, 8 figures, 2 tables; open access article under the CC BY-NC-ND license (see http://creativecommons.org/licenses/by-nc-nd/4.0/

SYNCHRONIZATION AND TOWING EFFECT ON ADULT ONE-DOG CANICROSS PERFORMANCE

Canicross is competitive team sport in which a human athlete is towed via a canine athlete on an elastic gangline. Although human performance factors play a role in the success of the canicross team, the interaction between human and canine athletes may also play a crucial role on the performance of the team. The purpose of this study was to assess the synchronization patterns across different locations in competitive canicross events and investigate the influences of canine mass on a timed trial event. Video was taken at five locations along the trail of two different competitive canicross events. Synchronization was mapped and a total synchronization score was given to each of the 19 canicross teams. The results of the current study suggest that neither synchronization score nor human to canine mass ratios were correlated with performance

Demographic characteristics of Australian humpback dolphins reveal important habitat toward the southwestern limit of their range

Open Access under Creative Commons by Attribution Licence. Use, distribution and reproduction are un-restricted. Authors and original publication must be credited.ABSTRACT: The paucity of information on the recently described Australian humpback dolphin Sousa sahulensis has hindered assessment of its conservation status. Here, we applied capture-recapture models to photo-identification data collected during boat-based surveys between 2013 and 2015 to estimate the abundance, site fidelity and residence patterns of Australian humpback dolphins around the North West Cape (NWC), Western Australia. Using Pollock’s closed robust design, abundance estimates varied from 65 to 102 individuals, and POPAN open modelling yielded a super-population size of 129 individuals in the 130 km2 study area. At approximately 1 humpback dolphin per km2, this density is the highest recorded for this species. Temporary emigration was Markovian, suggesting seasonal movement in and out of the study area. Hierarchical clustering showed that 63% of individuals identified exhibited high levels of site fidelity. Analysis of lagged identification rates indicated dolphins use the study area regularly, following a movement model characterised by emigration and re-immigration. These density, site fidelity and residence patterns indicate that the NWC is an important habitat toward the southwestern limit of this species’ range. Much of the NWC study area lies within a Marine Protected Area, offering a regulatory framework on which to base the management of human activities with the potential to impact this threatened species. Our methods provide a methodological framework to be used in future environmental impact assessments, and our findings represent a baseline from which to develop long-term studies to gain a more complete understanding of Australian humpback dolphin population dynamics

Retrofit 2050:Critical challenges for urban transitions

Scaling up retrofit presents a number of critical challenges for the transition to urban sustainability. Drawing together insights from the EPSRC Retrofit 2050 project this briefing sets out key success factors that need to be in place to deliver sustainable futures for UK cities

Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia.

PURPOSE OF REVIEW: The present investigation is a comprehensive review regarding the use of Suvorexant for insomnia treatment. It covers the background, pathophysiology, and significance of addressing insomnia, the pharmaceutical details of Suvorexant, and its safety, efficacy, and implications in treating insomnia. We further discuss Suvorexant\u27s role in targeting insomnia with other comorbidities. RECENT FINDINGS: Insomnia refers to poor quality and/or quantity of sleep. While there are many existing treatments such as benzodiazepines, melatonin agonists, TCAs, and atypical antipsychotics used to target various receptors involved in normal induction and maintenance of sleep, Suvorexant is an antagonist that specifically targets orexin receptors. Recent clinical studies suggest that Suvorexant is both clinically safe and effective. Quantity and quality of sleep are measured in various ways, yet the consensus points towards Suvorexant\u27s effectiveness in improving sleep time, onset, latency, and quality compared to placebo. In addition to helping improve isolated insomnia, Suvorexant helps improve sleep in patients that have other comorbidities such as obstructive sleep apnea, Alzheimer\u27s disease, dementia, acute stroke, and delirium. While Suvorexant is safe, there are still adverse effects associated with the drug that needs to be considered. The most common adverse effects include dizziness, somnolence, headaches, and cognitive impairment. SUMMARY: Insomnia is a major public health concern that affects many people worldwide and has been linked to many adverse health outcomes. While there are existing treatments that target different receptors and pathways of normal sleep induction and maintenance, Suvorexant is a novel drug that targets dual orexin receptors. Its safety and efficacy, mechanism of action, pharmacokinetic parameters, and relative lack of rebound and withdrawal effects render suvorexant a reliable choice for the treatment of insomnia

Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis

Testing for hepatitis C virus (HCV) infection may reduce the risk of liver-related morbidity, by facilitating earlier access to treatment and care. This review investigated the effectiveness of targeted testing interventions on HCV case detection, treatment uptake, and prevention of liver-related morbidity. A literature search identified studies published up to 2013 that compared a targeted HCV testing intervention (targeting individuals or groups at increased risk of HCV) with no targeted intervention, and results were synthesised using meta-analysis. Exposure to a targeted testing intervention, compared to no targeted intervention, was associated with increased cases detected [number of studies (n) = 14; pooled relative risk (RR) 1.7, 95 % CI 1.3, 2.2] and patients commencing therapy (n = 4; RR 3.3, 95 % CI 1.1, 10.0). Practitioner-based interventions increased test uptake and cases detected (n = 12; RR 3.5, 95 % CI 2.5, 4.8; and n = 10; RR 2.2, 95 % CI 1.4, 3.5, respectively), whereas media/information-based interventions were less effective (n = 4; RR 1.5, 95 % CI 0.7, 3.0; and n = 4; RR 1.3, 95 % CI 1.0, 1.6, respectively). This meta-analysis provides for the first time a quantitative assessment of targeted HCV testing interventions, demonstrating that these strategies were effective in diagnosing cases and increasing treatment uptake. Strategies involving practitioner-based interventions yielded the most favourable outcomes. It is recommended that testing should be targeted at and offered to individuals who are part of a population with high HCV prevalence, or who have a history of HCV risk behaviour

K201 improves aspects of the contractile performance of human failing myocardium via reduction in Ca2+ leak from the sarcoplasmic reticulum

In heart failure, intracellular Ca2+ leak from cardiac ryanodine receptors (RyR2s) leads to a loss of Ca2+ from the sarcoplasmic reticulum (SR) potentially contributing to decreased function. Experimental data suggest that the 1,4-benzothiazepine K201 (JTV-519) may stabilise RyR2s and thereby reduce detrimental intracellular Ca2+ leak. Whether K201 exerts beneficial effects in human failing myocardium is unknown. Therefore, we have studied the effects of K201 on muscle preparations from failing human hearts. K201 (0.3 μM; extracellular [Ca2+]e 1.25 mM) showed no effects on contractile function and micromolar concentrations resulted in negative inotropic effects (K201 1 μM; developed tension −9.8 ± 2.5% compared to control group; P < 0.05). Interestingly, K201 (0.3 μM) increased the post-rest potentiation (PRP) of failing myocardium after 120 s, indicating an increased SR Ca2+ load. At high [Ca2+]e concentrations (5 mmol/L), K201 increased PRP already at shorter rest intervals (30 s). Strikingly, treatment with K201 (0.3 μM) prevented diastolic dysfunction (diastolic tension at 5 mmol/L [Ca2+]e normalised to 1 mmol/L [Ca2+]e: control 1.26 ± 0.06, K201 1.01 ± 0.03, P < 0.01). In addition at high [Ca2+]e, K201 (0.3 μM) treatment significantly improved systolic function [developed tension +27 ± 8% (K201 vs. control); P < 0.05]. The beneficial effects on diastolic and systolic functions occurred throughout the physiological frequency range of the human heart rate from 1 to 3 Hz. Upon elevated intracellular Ca2+ concentration, systolic and diastolic contractile functions of terminally failing human myocardium are improved by K201